SPEAKERS

Gregory Lip

Derek Connolly,
MBChB (Edin),PhD (Cantab), FRCP

Consultant Cardiologist
Birmingham City & Sandwell Hospitals
Director of Research & Development
Sandwell & West Birmingham Hospitals NHS Trust
Birmingham, United Kingdom

SEE BIO
Gregory Lip

Renato D. Lopes,
MD, MHS, PhD, FACC

Professor of Medicine
Duke University Medical Center;
Director of Clinical Events Classification
Duke Clinical Research Institute
North Carolina, United States

SEE BIO
GuangMing Tan

George K. Andrikopoulos,
MD, PhD, FESC, FEHRA

Director
First Cardiac Department &
Electrophysiology and Pacing Department,
Henry Dunant Hospital Center
Athens, Greece

SEE BIO
Dan Gaita

Ștefan-Nicolae Bogdan
MD, PhD

Associate Professor
Department of Cardiology
Elias Emergency University Hospital
Bucharest, Romania

SEE BIO
Renata Główczyńska

Dariusz Dudek,
MD, PhD, FESC

Professor of Cardiology
Jagiellonian University Medical College
Krakow, Poland

SEE BIO
schedule

SCHEDULE

22 February 2025 (Saturday)
Country Time
Colombia02:30-10:00
Croatia, Czech Republic,
Hungary, Poland, Slovakia
08:30-16:00
Bulgaria, Greece, Latvia,
Romania, Bahrain, Kuwait,
Iraq, Qatar, Saudi Arabia
09:30-17:00
Oman,
The United Arab Emirates
11:30-19:00
India13:00-20:30
Indonesia, Thailand,
Vietnam
14:30-22:00
Hong Kong, Malaysia,
Philippines, Taiwan,
Singapore
15:30-23:00
REGISTER
Duration
Topic
Speakers
10 mins
Welcome remarks & Introduction to Session 1
Pfizer & Derek Connolly
35 mins
Revisiting a decade of progress in nvAF management
Renato Lopes
25 mins
Beyond clinical trials – Realizing outcomes in the real-world setting
George Andrikopoulos
15 mins
Panel discussion
All
15 mins
Break
25 mins
Switching between DOACs – Insights from the ATHENS study
Ștefan-Nicolae Bogdan
30 mins
Guidelines in practice: Key recommendations for nvAF management
Dariusz Dudek
15 mins
Panel discussion
All
70 mins
Break
5 mins
Introduction to Session 2
Renato Lopes
15 mins
Navigating clinical dilemmas in oral anticoagulation
Renato Lopes
100 mins
Interactive case discussion
Case 1:
Managing nvAF in elderly/frail patients or patients with extreme body weight
George Andrikopoulos
Case 2: Managing nvAF in patients with comorbid kidney/liver dysfunction
Derek Connolly
Case 3: Managing nvAF in patients undergoing electrophysiological and CIED procedures
Ștefan-Nicolae Bogdan
Case 4: Managing nvAF in patients with ACS undergoing PCI
Dariusz Dudek
20 mins
Break
55 mins
Tech-enabled nvAF care: Friend or foe?
All
15 mins
Summary & Closing remarks
Pfizer & Renato Lopes

ACS, acute coronary syndrome; CIED, cardiovascular implantable electronic devices; DOACs, direct oral anticoagulants; nvAF, nonvalvular atrial fibrillation; PCI, percutaneous coronary intervention.